The following text contains information regarding the methods of preventing illness and selfcare while coping with it. It is to be used responsibly. The following procedures cannot supplement professional medical treatment and healing in case of health issues.
The text is not to be reproduced in any way without the written consent of the authors.
With the beginning of the new millennium, mankind has entered a realm ruled by stress, anxiety and other similar issues yet unknown to the human mind. These issues, often tied to the overwhelming amount of information we tend to receive daily, leave consequences both on our nervous and immune systems. Despite the amazing medical breakthroughs of the past century, we simply cannot function without nature. Nature is the only constant presence in our lives and since we are born from it, it is only fair to at least try to acquire a certain amount of knowledge about its secrets.
Cannabis is perhaps the most perfect example of man’s dependence on nature; throughout history (leaving out the last two unfortunate centuries, when the prohibition of cannabis creates an ever-greater gap between man and nature), it has provided him with just about everything – it was the key ingredient of clothes, ropes, food, medicine, paper and other necessities of everyday life.
Due to the massive amount of unreliable information on cannabis circling the wide web, we wish to gather some key facts on its effect on human life, which can become more centered and relaxed with its prudent use.
Abrahamov A., Mechoulam R, An efficient new cannabinoid antiemetic in pediatric oncology, Life sci., 1995, 56, pp. 23-24.
Abrams DI., Guzman M., Can cannabis cure cancer?, JAMA Oncol. 2020, pp. 323-324.
Abrams DI., Guzman M., Cannabis in cancer care, Clin. Pharmacol. Ther. 2015, 97, pp. 575-86.
Ahmed A., van der Marck MA., van der ELSEN G., Cannabinoids in late – onset Alzheimer’s disease, Clin. Pharmacol. Ther. 2015, 97, pp. 597-606.
Andre CM., Hausman JF., Guerriero G., Cannabis sativa: the plant of the thousand and one molecules, Front Plant Sci., 2016, 7.
Appendino G., Gibbons S., Gianna A., Pagani A., Grassi G., Stavri M., Smith E., Antibacterial cannabinoids from Cannabis sativa: a structure-activity study, J. Nat Prod., 2008, 71, pp. 1427-30.
Ar K., Bhatnagar S, Use of cannabis and cannabinoids in palliative care setting, Curr. Opin. Anaesthesiol 2020, 33, pp. 841-46.
Gates, P., Copeland, J., Swift, W., & Martin, G. (2012). Barriers and facilitators to cannabis treatment. Drug and alcohol review, 31(3), 311-319.
Martín-Sánchez, E., Furukawa, T. A., Taylor, J., & Martin, J. L. R. (2009). Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain medicine, 10(8), 1353-1368.
Rooke, S., Copeland, J., Norberg, M., Hine, D., & McCambridge, J. (2013). Effectiveness of a self-guided web-based cannabis treatment program: randomized controlled trial. Journal of medical Internet research, 15(2), e26.
Turna, J., Patterson, B., & Van Ameringen, M. (2017). Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?. Depression and anxiety, 34(11), 1006-1017.
Schleider, L. B. L., Mechoulam, R., Saban, N., Meiri, G., & Novack, V. (2019). Real life experience of medical cannabis treatment in autism: analysis of safety and efficacy. Scientific reports, 9(1), 1-7.
Li, X., Vigil, J. M., Stith, S. S., Brockelman, F., Keeling, K., & Hall, B. (2019). The effectiveness of self-directed medical cannabis treatment for pain. Complementary therapies in medicine, 46, 123-130.
Nordstrom, B. R., & Levin, F. R. (2007). Treatment of cannabis use disorders: a review of the literature. The American journal on addictions, 16(5), 331-342.
Lahat, A., Lang, A., & Ben-Horin, S. (2012). Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study. Digestion, 85(1), 1-8.
Marlatt, G. A. (2006). Cannabis dependence: its nature, consequences and treatment. Cambridge university press.
Stiglick, A., & Kalant, H. (1985). Residual effects of chronic cannabis treatment on behavior in mature rats. Psychopharmacology, 85(4), 436-439.
Savage, S. R., Romero-Sandoval, A., Schatman, M., Wallace, M., Fanciullo, G., McCarberg, B., & Ware, M. (2016). Cannabis in pain treatment: clinical and research considerations. The Journal of Pain, 17(6), 654-668.
Solowij, N., Stephens, R. S., Roffman, R. A., Babor, T., Kadden, R., Miller, M., … & Marijuana Treatment Project Research Group. (2002). Cognitive functioning of long-term heavy cannabis users seeking treatment. Jama, 287(9), 1123-1131.
Lintzeris, N., Bhardwaj, A., Mills, L., Dunlop, A., Copeland, J., McGregor, I., … & Allsop, D. (2019). Nabiximols for the treatment of cannabis dependence: a randomized clinical trial. JAMA internal medicine, 179(9), 1242-1253.
Dennis, M., Godley, S. H., Diamond, G., Tims, F. M., Babor, T., Donaldson, J., … & Funk, R. (2004). The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. Journal of substance abuse treatment, 27(3), 197-213.
Naftali, T., Lev, L. B., Yablecovitch, D., Half, E., & Konikoff, F. M. (2011). Treatment of Crohn’s disease with cannabis: an observational study. The Israel Medical Association journal: IMAJ, 13(8), 455-458.
Copersino, M. L., Boyd, S. J., Tashkin, D. P., Huestis, M. A., Heishman, S. J., Dermand, J. C., … & Gorelick, D. A. (2006). Cannabis withdrawal among non‐treatment‐seeking adult cannabis users. The American Journal on Addictions, 15(1), 8-14.
M Weinstein, A., & A Gorelick, D. (2011). Pharmacological treatment of cannabis dependence. Current pharmaceutical design, 17(14), 1351-1358.
Gaston, T. E., & Szaflarski, J. P. (2018). Cannabis for the treatment of epilepsy: an update. Current neurology and neuroscience reports, 18(11), 1-9.
Abuhasira, R., Schleider, L. B. L., Mechoulam, R., & Novack, V. (2018). Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European journal of internal medicine, 49, 44-50.
Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2018). Cannabis for the treatment of Crohn’s disease. Cochrane Database of Systematic Reviews, (11).
Habib, G., & Artul, S. (2018). Medical cannabis for the treatment of fibromyalgia. JCR: Journal of Clinical Rheumatology, 24(5), 255-258.
Scherma, M., Masia, P., Deidda, M., Fratta, W., Tanda, G., & Fadda, P. (2018). New perspectives on the use of cannabis in the treatment of psychiatric disorders. Medicines, 5(4), 107.
Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2018). Cannabis for the treatment of ulcerative colitis. Cochrane Database of Systematic Reviews, (11).
Lucas, P. (2012). Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain. Journal of psychoactive drugs, 44(2), 125-133.
Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., … & Pogarell, O. (2019). How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review. European archives of psychiatry and clinical neuroscience, 269(1), 87-105.
MacCallum, C. A., & Russo, E. B. (2018). Practical considerations in medical cannabis administration and dosing. European journal of internal medicine, 49, 12-19.
Agarwal, R., Burke, S. L., & Maddux, M. (2019). Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. BMC psychiatry, 19(1), 1-10.
Dennis, M., Titus, J. C., Diamond, G., Donaldson, J., Godley, S. H., Tims, F. M., … & CYT Steering Committee. (2002). The Cannabis Youth Treatment (CYT) experiment: rationale, study design and analysis plans. Addiction, 97, 16-34.
Blake, D. R., Robson, P., Ho, M., Jubb, R. W., & McCabe, C. S. (2006). Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology, 45(1), 50-52.
Copeland, J., & Maxwell, J. C. (2007). Cannabis treatment outcomes among legally coerced and non-coerced adults. BMC Public Health, 7(1), 1-7.
Russo, E. (1998). Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. Pain, 76(1-2), 3-8.
Campbell, G., Stockings, E., & Nielsen, S. (2019). Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. European archives of psychiatry and clinical neuroscience, 269(1), 135-144.
Miller, R. J., & Miller, R. E. (2017). Is cannabis an effective treatment for joint pain. Clin Exp Rheumatol, 35(5), 59-67.
Press, C. A., Knupp, K. G., & Chapman, K. E. (2015). Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy & Behavior, 45, 49-52.
Haroutounian, S., Ratz, Y., Ginosar, Y., Furmanov, K., Saifi, F., Meidan, R., & Davidson, E. (2016). The effect of medicinal cannabis on pain and quality-of-life outcomes in chronic pain. The Clinical journal of pain, 32(12), 1036-1043.
Russo, E. B. (2017). Cannabis and epilepsy: an ancient treatment returns to the fore. Epilepsy & Behavior, 70, 292-297.
Porter, B. E., & Jacobson, C. (2013). Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy & Behavior, 29(3), 574-577.
Aggarwal, S. K., Carter, G. T., Sullivan, M. D., ZumBrunnen, C., Morrill, R., & Mayer, J. D. (2009). Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State. Journal of Opioid Management, 5(5), 257-286.
Mechoulam, R. (2012, February). Cannabis—a valuable drug that deserves better treatment. In Mayo Clinic Proceedings (Vol. 87, No. 2, pp. 107-109). Elsevier.
Hausman-Kedem, M., Menascu, S., & Kramer, U. (2018). Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents–An observational, longitudinal study. Brain and Development, 40(7), 544-551.
Lakhan, S. E., & Rowland, M. (2009). Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC neurology, 9(1), 1-6.
Berman, P., Sulimani, L., Gelfand, A., Amsalem, K., Lewitus, G. M., & Meiri, D. (2020). Cannabinoidomics–An analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolome. Talanta, 219, 121336.
Babson, K. A., & Bonn-Miller, M. O. (2014). Sleep disturbances: Implications for cannabis use, cannabis use cessation, and cannabis use treatment. Current Addiction Reports, 1(2), 109-114.
Schleider, L. B. L., Mechoulam, R., Lederman, V., Hilou, M., Lencovsky, O., Betzalel, O., … & Novack, V. (2018). Prospective analysis of safety and efficacy of medical cannabis in large, unselected population of patients with cancer. European journal of internal medicine, 49, 37-43.